Brief: Clinical Laserthermia Systems Gets FDA Clearance For Expanded Labeling

Clinical Laserthermia Systems AB

04/09/2025 16:01

Sept 4 (Reuters) - Clinical Laserthermia Systems AB CLSRb.ST:

CLINICAL LASERTHERMIA SYSTEMS RECEIVES FDA CLEARANCE FOR EXPANDED LABELING OF THE CLEARPOINT PRISM[®] NEURO LASER THERAPY SYSTEM, DOUBLING THE ADDRESSABLE U.S MARKET FOR NEURO LITT

Source text: ID:nWkr848rVY

Further company coverage: [CLSRb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))